SoftBank Group has partnered with Tempus AI to create a new joint venture aimed at utilizing artificial intelligence (AI) to analyze personal medical data and provide treatment recommendations. SoftBank Group CEO Masayoshi Son announced the news at a press conference in Tokyo.

SoftBank Group's stock price climbed due to Masayoshi Son's plan to establish a $10 billion AI chip company. Son will invest $30 billion, with plans to name the company Izanagi, competing in the global semiconductor market. This initiative could surpass Microsoft's investment in OpenAI, and Son has high hopes for the future of artificial intelligence. SoftBank's stock rose by 30%, as Son sees immense opportunities in the AI sector.

SoftBank Group founder Masayoshi Son plans to raise up to $100 billion through a new chip startup project named Project Izanagi. The initiative aims to establish an AI chip company that will compete directly with Nvidia. The project will contribute to the development of Artificial General Intelligence (AGI), a field that Son is passionate about. This move is intended to make AGI a reality within the next decade, although it remains unclear whether the artificial intelligence processors of Project Izanagi will rely on the instruction set architecture (ISA) developed by Arm.